• Je něco špatně v tomto záznamu ?

TAp73 and ΔTAp73 isoforms show cell-type specific distributions and alterations in cancer

V. Hrabal, M. Stenckova, F. Zavadil Kokas, P. Muller, R. Nenutil, B. Vojtesek, PJ. Coates

. 2024 ; 14 (1) : 29949. [pub] 20241202

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc25003111

Grantová podpora
MMCI 00209805 Ministerstvo Zdravotnictví Ceské Republiky
GACR 23-05951S Grantová Agentura České Republiky

TP73 is a member of the TP53 gene family and produces N- and C-terminal protein isoforms through alternative promoters, alternative translation initiation and alternative splicing. Most notably, p73 protein isoforms may either contain a p53-like transactivation domain (TAp73 isoforms) or lack this domain (ΔTAp73 isoforms) and these variants have opposing or independent functions. To date, there is a lack of well-characterised isoform-specific p73 antibodies. Here, we produced polyclonal and monoclonal antibodies to N-terminal p73 variants and the C-terminal p73α isoform, the most common variant in human tissues. These reagents show that TAp73 is a marker of multiciliated epithelial cells, while ΔTAp73 is a marker of non-proliferative basal/reserve cells in squamous epithelium. We were unable to detect ΔNp73 variant proteins, in keeping with recent data that this is a minor form in human tissues. Most cervical squamous cell carcinomas (79%) express p73α, and the distribution of staining in basal cells correlated with lower tumour grade. TAp73 was found in 17% of these tumours, with a random distribution and no association with clinicopathological features. These data indicate roles for ΔTAp73 in maintaining a non-proliferative state of undifferentiated squamous epithelial cells and for TAp73 in the production of differentiated multiciliated cells.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc25003111
003      
CZ-PrNML
005      
20250206104039.0
007      
ta
008      
250121s2024 enk f 000 0|eng||
009      
AR
024    7_
$a 10.1038/s41598-024-80927-9 $2 doi
035    __
$a (PubMed)39622910
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Hrabal, Vaclav $u Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic. vaclav.hrabal@mou.cz $u Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. vaclav.hrabal@mou.cz
245    10
$a TAp73 and ΔTAp73 isoforms show cell-type specific distributions and alterations in cancer / $c V. Hrabal, M. Stenckova, F. Zavadil Kokas, P. Muller, R. Nenutil, B. Vojtesek, PJ. Coates
520    9_
$a TP73 is a member of the TP53 gene family and produces N- and C-terminal protein isoforms through alternative promoters, alternative translation initiation and alternative splicing. Most notably, p73 protein isoforms may either contain a p53-like transactivation domain (TAp73 isoforms) or lack this domain (ΔTAp73 isoforms) and these variants have opposing or independent functions. To date, there is a lack of well-characterised isoform-specific p73 antibodies. Here, we produced polyclonal and monoclonal antibodies to N-terminal p73 variants and the C-terminal p73α isoform, the most common variant in human tissues. These reagents show that TAp73 is a marker of multiciliated epithelial cells, while ΔTAp73 is a marker of non-proliferative basal/reserve cells in squamous epithelium. We were unable to detect ΔNp73 variant proteins, in keeping with recent data that this is a minor form in human tissues. Most cervical squamous cell carcinomas (79%) express p73α, and the distribution of staining in basal cells correlated with lower tumour grade. TAp73 was found in 17% of these tumours, with a random distribution and no association with clinicopathological features. These data indicate roles for ΔTAp73 in maintaining a non-proliferative state of undifferentiated squamous epithelial cells and for TAp73 in the production of differentiated multiciliated cells.
650    _2
$a lidé $7 D006801
650    12
$a protein p73 $x metabolismus $x genetika $7 D000072160
650    12
$a protein - isoformy $x metabolismus $x genetika $7 D020033
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a spinocelulární karcinom $x metabolismus $x patologie $x genetika $7 D002294
650    _2
$a nádory děložního čípku $x metabolismus $x patologie $x genetika $7 D002583
650    _2
$a zvířata $7 D000818
650    _2
$a epitelové buňky $x metabolismus $7 D004847
650    _2
$a nádorové buněčné linie $7 D045744
650    _2
$a nádory $x metabolismus $x patologie $x genetika $7 D009369
650    _2
$a monoklonální protilátky $7 D000911
655    _2
$a časopisecké články $7 D016428
700    1_
$a Stenckova, Michaela $u Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic
700    1_
$a Zavadil Kokas, Filip $u Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic
700    1_
$a Muller, Petr $u Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic
700    1_
$a Nenutil, Rudolf $u Department of Pathology, Masaryk Memorial Cancer Institute, Brno, Czech Republic
700    1_
$a Vojtesek, Borivoj $u Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic
700    1_
$a Coates, Philip J $u Research Center for Applied Molecular Oncology (RECAMO), Masaryk Memorial Cancer Institute, Zluty kopec 7, Brno, 656 53, Czech Republic. philip.coates@mou.cz
773    0_
$w MED00182195 $t Scientific reports $x 2045-2322 $g Roč. 14, č. 1 (2024), s. 29949
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39622910 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20250121 $b ABA008
991    __
$a 20250206104035 $b ABA008
999    __
$a ok $b bmc $g 2263082 $s 1239118
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 14 $c 1 $d 29949 $e 20241202 $i 2045-2322 $m Scientific reports $n Sci Rep $x MED00182195
GRA    __
$a MMCI 00209805 $p Ministerstvo Zdravotnictví Ceské Republiky
GRA    __
$a GACR 23-05951S $p Grantová Agentura České Republiky
LZP    __
$a Pubmed-20250121

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...